These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20167793)

  • 21. Microdose study of 14C-acetaminophen with accelerator mass spectrometry to examine pharmacokinetics of parent drug and metabolites in healthy subjects.
    Tozuka Z; Kusuhara H; Nozawa K; Hamabe Y; Ikushima I; Ikeda T; Sugiyama Y
    Clin Pharmacol Ther; 2010 Dec; 88(6):824-30. PubMed ID: 21048707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in microdosing and other exploratory human pharmacokinetic studies for early drug development.
    Oosterhuis B
    Bioanalysis; 2010 Mar; 2(3):377-9. PubMed ID: 21083246
    [No Abstract]   [Full Text] [Related]  

  • 23. Microdosing of a Carbon-14 Labeled Protein in Healthy Volunteers Accurately Predicts Its Pharmacokinetics at Therapeutic Dosages.
    Vlaming ML; van Duijn E; Dillingh MR; Brands R; Windhorst AD; Hendrikse NH; Bosgra S; Burggraaf J; de Koning MC; Fidder A; Mocking JA; Sandman H; de Ligt RA; Fabriek BO; Pasman WJ; Seinen W; Alves T; Carrondo M; Peixoto C; Peeters PA; Vaes WH
    Clin Pharmacol Ther; 2015 Aug; 98(2):196-204. PubMed ID: 25869840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of capillary high performance liquid chromatography with electrospray mass spectrometry for the analysis of small volume blood samples from serially bled mice to determine the pharmacokinetics of early discovery compounds.
    Fraser IJ; Dear GJ; Plumb R; L'Affineur M; Fraser D; Skippen AJ
    Rapid Commun Mass Spectrom; 1999; 13(23):2366-75. PubMed ID: 10567936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis.
    Bruce SJ; Jonsson P; Antti H; Cloarec O; Trygg J; Marklund SL; Moritz T
    Anal Biochem; 2008 Jan; 372(2):237-49. PubMed ID: 17964273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microdosing: the new pharmacokinetic paradigm?
    Zanni GR; Wick JY
    Consult Pharm; 2006 Oct; 21(10):756-76. PubMed ID: 17243857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microdosing studies in humans: the role of positron emission tomography.
    Bauer M; Wagner CC; Langer O
    Drugs R D; 2008; 9(2):73-81. PubMed ID: 18298126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching.
    Mueller CA; Weinmann W; Dresen S; Schreiber A; Gergov M
    Rapid Commun Mass Spectrom; 2005; 19(10):1332-8. PubMed ID: 15852450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of accelerator MS in pediatric drug evaluation.
    Vuong LT; Blood AB; Vogel JS; Anderson ME; Goldstein B
    Bioanalysis; 2012 Aug; 4(15):1871-82. PubMed ID: 22943618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a 250 kV single-stage accelerator mass spectrometer with a 5 MV tandem accelerator mass spectrometer--fitness for purpose in bioanalysis.
    Young GC; Corless S; Felgate CC; Colthup PV
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4035-42. PubMed ID: 19009519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of accelerator mass spectrometry for pharmacological and toxicological research.
    Brown K; Tompkins EM; White IN
    Mass Spectrom Rev; 2006; 25(1):127-45. PubMed ID: 16059873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automation of in-tip solid-phase microextraction in 96-well format for the determination of a model drug compound in human plasma by liquid chromatography with tandem mass spectrometric detection.
    Xie W; Mullett WM; Miller-Stein CM; Pawliszyn J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):415-20. PubMed ID: 19144575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry.
    Hopfgartner G; Bourgogne E
    Mass Spectrom Rev; 2003; 22(3):195-214. PubMed ID: 12838545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological accelerator mass spectrometry at Uppsala University.
    Salehpour M; Possnert G; Bryhni H; Palminger-Hallén I; Ståhle L
    Appl Radiat Isot; 2009 Mar; 67(3):495-9. PubMed ID: 18789710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
    Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turbulent flow chromatography TFC-tandem mass spectrometry supporting in vitro/vivo studies of NCEs in high throughput fashion.
    Verdirame M; Veneziano M; Alfieri A; Di Marco A; Monteagudo E; Bonelli F
    J Pharm Biomed Anal; 2010 Mar; 51(4):834-41. PubMed ID: 19896318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lead optimization strategies as part of a drug metabolism environment.
    Korfmacher WA
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):481-5. PubMed ID: 12951811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.
    Burt T; John CS; Ruckle JL; Vuong LT
    Expert Opin Drug Deliv; 2017 May; 14(5):657-672. PubMed ID: 27564533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.